85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details
臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00189176 (ClinicalTrials.gov) | March 2003 | 10/9/2005 | Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis | Phase I/II Trial of Tetrathiomolybdate (TM) in Patients With Usual Interstitial Pneumonia Refractory to Previous Therapy | Idiopathic Pulmonary Fibrosis | Drug: Tetrathiomolybdate | University of Michigan | Coalition for Pulmonary Fibrosis | Completed | 35 Years | 80 Years | Both | 23 | Phase 1/Phase 2 | United States |